National Toxicology Program (NTP); Office of Liaison, Policy and Review; Meeting of the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM), 19562-19563 [E9-9845]

Download as PDF 19562 Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices Æ 1 member shall be from a labor organization representing health care workers; Æ 1 member shall have expertise in health information privacy and security; Æ 1 member shall have expertise in improving the health of vulnerable populations; Æ 1 member shall be from the research community; Æ 1 member shall represent health plans or other third-party payers; Æ 1 member shall represent information technology vendors; Æ 1 member shall represent purchasers or employers; and Æ 1 member shall have expertise in health care quality measurement and reporting. Non-federal members of the Committee shall be Special Government Employees, unless classified as representatives. III. Copies of the Charter Dated: April 23, 2009. David Blumenthal, National Coordinator for Health Information Technology, Office of the National Coordinator for Health Information Technology. [FR Doc. E9–9839 Filed 4–24–09; 4:15 pm] BILLING CODE 4150–45–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the National Coordinator for Health Information Technology pwalker on PROD1PC71 with NOTICES ACTION: Notification of the Establishment of the HIT Standards Committee. SUMMARY: This notice announces the establishment of the HIT Standards Committee. The American Recovery and Reinvestment Act of 2009 (ARRA) (Pub. L. 111–5), section 13101, directs the establishment of the HIT Standards Committee. The HIT Standards Committee (also referred to as the ‘‘Committee’’) is charged with making recommendations to the National Coordinator on standards, implementation specifications, and certification criteria for the electronic exchange and use of health information for purposes of adoption, consistent with the implementation of the Federal Health IT Strategic Plan, and in accordance with policies developed by the HIT Policy Committee. FOR FURTHER INFORMATION CONTACT: Judith Sparrow, Office of the National 17:48 Apr 28, 2009 SUPPLEMENTARY INFORMATION: I. Background The Committee and its staff are governed by the provisions of the Federal Advisory Committee Act (FACA) (Pub. L. 92–463), as amended, (5 U.S.C. App.), which sets forth standards for the formation and use of federal advisory committees. The Committee shall determine a schedule of meetings following an election of a Chairperson and a Vice Chairperson from among its members. An initial meeting of the Committee shall take place not later than 90 days from passage of the ARRA. II. Criteria for Members To obtain a copy of the Committee’s charter, submit a written request to the above contact. VerDate Nov<24>2008 Coordinator for Health Information Technology, e-mail judy.sparrow@hhs.gov or 202–205– 4528. Jkt 217001 The HIT Standards Committee shall not exceed thirty (30) voting members, including a Chair and Vice Chair, and members are appointed by the Secretary with input from the National Coordinator. Membership of the Committee shall at least reflect providers, ancillary healthcare workers, consumers, purchasers, health plans, technology vendors, researchers, relevant Federal agencies, and individuals with technical expertise on health care quality, privacy and security, and on the electronic exchange and use of health information and shall represent a balance among various sectors of the health care system so that no single sector unduly influences the recommendations of the Committee. Non-Federal members of the Committee shall be Special Government Employees, unless classified as representatives. III. Copies of the Charter To obtain a copy of the Committee’s charter, submit a written request to the above contact. Dated: April 23, 2009. David Blumenthal, National Coordinator for Health Information Technology, Office of the National Coordinator for Health Information Technology. [FR Doc. E9–9838 Filed 4–24–09; 4:15 pm] BILLING CODE 4150–45–P PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Toxicology Program (NTP); Office of Liaison, Policy and Review; Meeting of the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM) AGENCY: National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH). ACTION: Meeting announcement and request for comments. SUMMARY: Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of SACATM on June 25–26, 2009, at the Hilton Arlington Hotel, 950 North Stafford Street, Arlington, VA 22203. The meeting is open to the public with attendance limited only by the space available. SACATM advises the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), and the Director of the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and activities of NICEATM. DATES: The SACATM meeting will be held on June 25 and 26, 2009. The meeting is scheduled from 8:30 a.m. to 5 p.m. on June 25 and 8:30 a.m. until adjournment on June 26, 2009. All individuals who plan to attend are encouraged to register online at the NTP Web site (https://ntp.niehs.nih.gov/go/ 7441) by June 17, 2009. In order to facilitate planning, persons wishing to make an oral presentation are asked to notify Dr. Lori White, NTP Executive Secretary, via online registration, phone, or e-mail by June 17, 2009 (see ADDRESSES below). Written comments should also be received by June 17, 2009, to enable review by SACATM and NIEHS/NTP staff before the meeting. ADDRESSES: The SACATM meeting will be held at the Hilton Arlington Hotel, 950 North Stafford Street, Arlington, VA 22203 [hotel: (703) 528–6000)]. Public comments and other correspondence should be directed to Dr. Lori White (NTP Office of Liaison, Policy and Review, NIEHS, P.O. Box 12233, MD K2–03, Research Triangle Park, NC 27709; telephone: 919–541–9834 or email: whiteld@niehs.nih.gov). Courier address: NIEHS, 530 Davis Drive, Room 2136, Durham, NC 27713. Persons needing interpreting services in order to attend should contact 301–402–8180 (voice) or 301–435–1908 (TTY). E:\FR\FM\29APN1.SGM 29APN1 Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices allowed for presentation by on-site registrants may be less than for preregistered speakers and will be determined by the number of persons Preliminary Agenda Topics and who register at the meeting. Availability of Meeting Materials Persons registering to make oral comments are asked to do so through Preliminary agenda topics include: the online registration form (https:// • NICEATM–ICCVAM Update. • Regulatory Acceptance of ICCVAM– ntp.niehs.nih.gov/go/7441) and to send a copy of their statement to Dr. White Recommended Alternative Test (see ADDRESSES above) by June 17, 2009, Methods. • NRC Report Recognition and to enable review by SACATM, Alleviation of Pain in Laboratory NICEATM–ICCVAM, and NIEHS/NTP Animals. staff prior to the meeting. Written • Implementation of NICEATM– statements can supplement and may ICCVAM Five-Year Plan. expand the oral presentation. If • Federal Agency Research, registering on-site and reading from Development, Translation, and written text, please bring 40 copies of Validation Activities Relevant to the the statement for distribution and to NICEATM–ICCVAM Five-Year Plan supplement the record. (EPA and USDA). Background Information on ICCVAM, • Report on second meeting of NICEATM, and SACATM Independent Peer Review Panel: ICCVAM is an interagency committee Evaluation of the Updated Validation composed of representatives from 15 Status of New Versions and Federal regulatory and research agencies Applications of the Murine Local that use, generate, or disseminate Lymph Node Assay: Assessing the toxicological information. ICCVAM Allergic Contact Dermatitis Potential of conducts technical evaluations of new, Chemicals and Products. revised, and alternative methods with • Report on the Independent regulatory applicability and promotes Scientific Peer Review Panel on the development, scientific validation, Alternative Ocular Safety Testing regulatory acceptance, implementation, Methods. • Update from the Japanese Center for and national and international harmonization of new, revised, and the Validation of Alternative Methods. alternative toxicological test methods • Update from the European Centre that more accurately assess the safety for the Evaluation of Alternative and hazards of chemicals and products Methods. and that refine, reduce, and replace • Update from Health Canada. A copy of the preliminary agenda, animal use. The ICCVAM Authorization committee roster, and additional Act of 2000 [42 U.S.C. 285l–3] information, when available, will be established ICCVAM as a permanent interagency committee of the NIEHS posted on the NTP Web site (https:// under NICEATM. NICEATM ntp.niehs.nih.gov/go/7441) or available administers ICCVAM and provides upon request (see ADDRESSES above). scientific and operational support for Following the SACATM meeting, ICCVAM-related activities. NICEATM summary minutes will be prepared and and ICCVAM work collaboratively to available on the NTP Web site or upon evaluate new and improved test request. methods applicable to the needs of U.S. Request for Comments Federal agencies. Additional Both written and oral public input on information about ICCVAM and the agenda topics is invited. Written NICEATM can be found on their Web comments received in response to this site (https://iccvam.niehs.nih.gov). notice will be posted on the NTP Web SACATM was established in response site. Persons submitting written to the ICCVAM Authorization Act comments should include their name, [Section 285l–3(d)] and is composed of affiliation (if applicable), and scientists from the public and private sponsoring organization (if any) with sectors. SACATM advises ICCVAM, the document. Time is allotted during NICEATM, and the Director of the the meeting for presentation of oral NIEHS and NTP regarding statutorily comments and each organization is mandated duties of ICCVAM and allowed one time slot per public activities of NICEATM. SACATM comment period. At least 7 minutes will provides advice on priorities and be allotted for each speaker, and if time activities related to the development, permits, may be extended up to 10 validation, scientific review, regulatory minutes at the discretion of the chair. acceptance, implementation, and Registration for oral comments will also national and international be available on-site, although time harmonization of new, revised, and pwalker on PROD1PC71 with NOTICES Requests should be made at least 7 days in advance of the meeting. SUPPLEMENTARY INFORMATION: VerDate Nov<24>2008 17:48 Apr 28, 2009 Jkt 217001 PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 19563 alternative toxicological test methods. Additional information about SACATM, including the charter, roster, and records of past meetings, can be found at https://ntp.niehs.nih.gov/go/167. Dated: April 22, 2009. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. E9–9845 Filed 4–28–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-09–0128] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 or send comments to Maryam Daneshvar, CDC Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Congenital Syphilis (CS) Case Investigation and Report Form (CDC73.126), OMB No. 0920–0128— revision—National Center for HIV/ AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention, (NCHHSTP), Centers for Disease Control and Prevention (CDC). E:\FR\FM\29APN1.SGM 29APN1

Agencies

[Federal Register Volume 74, Number 81 (Wednesday, April 29, 2009)]
[Notices]
[Pages 19562-19563]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9845]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Toxicology Program (NTP); Office of Liaison, Policy and 
Review; Meeting of the Scientific Advisory Committee on Alternative 
Toxicological Methods (SACATM)

AGENCY: National Institute of Environmental Health Sciences (NIEHS), 
National Institutes of Health (NIH).

ACTION: Meeting announcement and request for comments.

-----------------------------------------------------------------------

SUMMARY: Pursuant to section 10(a) of the Federal Advisory Committee 
Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a 
meeting of SACATM on June 25-26, 2009, at the Hilton Arlington Hotel, 
950 North Stafford Street, Arlington, VA 22203. The meeting is open to 
the public with attendance limited only by the space available. SACATM 
advises the Interagency Coordinating Committee on the Validation of 
Alternative Methods (ICCVAM), the NTP Interagency Center for the 
Evaluation of Alternative Toxicological Methods (NICEATM), and the 
Director of the NIEHS and NTP regarding statutorily mandated duties of 
ICCVAM and activities of NICEATM.

DATES: The SACATM meeting will be held on June 25 and 26, 2009. The 
meeting is scheduled from 8:30 a.m. to 5 p.m. on June 25 and 8:30 a.m. 
until adjournment on June 26, 2009. All individuals who plan to attend 
are encouraged to register online at the NTP Web site (https://ntp.niehs.nih.gov/go/7441) by June 17, 2009. In order to facilitate 
planning, persons wishing to make an oral presentation are asked to 
notify Dr. Lori White, NTP Executive Secretary, via online 
registration, phone, or e-mail by June 17, 2009 (see ADDRESSES below). 
Written comments should also be received by June 17, 2009, to enable 
review by SACATM and NIEHS/NTP staff before the meeting.

ADDRESSES: The SACATM meeting will be held at the Hilton Arlington 
Hotel, 950 North Stafford Street, Arlington, VA 22203 [hotel: (703) 
528-6000)]. Public comments and other correspondence should be directed 
to Dr. Lori White (NTP Office of Liaison, Policy and Review, NIEHS, 
P.O. Box 12233, MD K2-03, Research Triangle Park, NC 27709; telephone: 
919-541-9834 or e-mail: whiteld@niehs.nih.gov). Courier address: NIEHS, 
530 Davis Drive, Room 2136, Durham, NC 27713. Persons needing 
interpreting services in order to attend should contact 301-402-8180 
(voice) or 301-435-1908 (TTY).

[[Page 19563]]

Requests should be made at least 7 days in advance of the meeting.

SUPPLEMENTARY INFORMATION:

Preliminary Agenda Topics and Availability of Meeting Materials

    Preliminary agenda topics include:
     NICEATM-ICCVAM Update.
     Regulatory Acceptance of ICCVAM-Recommended Alternative 
Test Methods.
     NRC Report Recognition and Alleviation of Pain in 
Laboratory Animals.
     Implementation of NICEATM-ICCVAM Five-Year Plan.
     Federal Agency Research, Development, Translation, and 
Validation Activities Relevant to the NICEATM-ICCVAM Five-Year Plan 
(EPA and USDA).
     Report on second meeting of Independent Peer Review Panel: 
Evaluation of the Updated Validation Status of New Versions and 
Applications of the Murine Local Lymph Node Assay: Assessing the 
Allergic Contact Dermatitis Potential of Chemicals and Products.
     Report on the Independent Scientific Peer Review Panel on 
Alternative Ocular Safety Testing Methods.
     Update from the Japanese Center for the Validation of 
Alternative Methods.
     Update from the European Centre for the Evaluation of 
Alternative Methods.
     Update from Health Canada.
    A copy of the preliminary agenda, committee roster, and additional 
information, when available, will be posted on the NTP Web site (https://ntp.niehs.nih.gov/go/7441) or available upon request (see ADDRESSES 
above). Following the SACATM meeting, summary minutes will be prepared 
and available on the NTP Web site or upon request.

Request for Comments

    Both written and oral public input on the agenda topics is invited. 
Written comments received in response to this notice will be posted on 
the NTP Web site. Persons submitting written comments should include 
their name, affiliation (if applicable), and sponsoring organization 
(if any) with the document. Time is allotted during the meeting for 
presentation of oral comments and each organization is allowed one time 
slot per public comment period. At least 7 minutes will be allotted for 
each speaker, and if time permits, may be extended up to 10 minutes at 
the discretion of the chair. Registration for oral comments will also 
be available on-site, although time allowed for presentation by on-site 
registrants may be less than for pre-registered speakers and will be 
determined by the number of persons who register at the meeting.
    Persons registering to make oral comments are asked to do so 
through the online registration form (https://ntp.niehs.nih.gov/go/7441) 
and to send a copy of their statement to Dr. White (see ADDRESSES 
above) by June 17, 2009, to enable review by SACATM, NICEATM-ICCVAM, 
and NIEHS/NTP staff prior to the meeting. Written statements can 
supplement and may expand the oral presentation. If registering on-site 
and reading from written text, please bring 40 copies of the statement 
for distribution and to supplement the record.

Background Information on ICCVAM, NICEATM, and SACATM

    ICCVAM is an interagency committee composed of representatives from 
15 Federal regulatory and research agencies that use, generate, or 
disseminate toxicological information. ICCVAM conducts technical 
evaluations of new, revised, and alternative methods with regulatory 
applicability and promotes the development, scientific validation, 
regulatory acceptance, implementation, and national and international 
harmonization of new, revised, and alternative toxicological test 
methods that more accurately assess the safety and hazards of chemicals 
and products and that refine, reduce, and replace animal use. The 
ICCVAM Authorization Act of 2000 [42 U.S.C. 285l-3] established ICCVAM 
as a permanent interagency committee of the NIEHS under NICEATM. 
NICEATM administers ICCVAM and provides scientific and operational 
support for ICCVAM-related activities. NICEATM and ICCVAM work 
collaboratively to evaluate new and improved test methods applicable to 
the needs of U.S. Federal agencies. Additional information about ICCVAM 
and NICEATM can be found on their Web site (https://iccvam.niehs.nih.gov).
    SACATM was established in response to the ICCVAM Authorization Act 
[Section 285l-3(d)] and is composed of scientists from the public and 
private sectors. SACATM advises ICCVAM, NICEATM, and the Director of 
the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and 
activities of NICEATM. SACATM provides advice on priorities and 
activities related to the development, validation, scientific review, 
regulatory acceptance, implementation, and national and international 
harmonization of new, revised, and alternative toxicological test 
methods. Additional information about SACATM, including the charter, 
roster, and records of past meetings, can be found at https://ntp.niehs.nih.gov/go/167.

    Dated: April 22, 2009.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. E9-9845 Filed 4-28-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.